Bottom line
How much do FBTAX and BIB overlap?
26% of their top holdings overlap by weight. 9 securities appear in both funds' top 25, making up 26.4% of FBTAX's assets and 22.1% of BIB's. They are substantially different portfolios, so owning both adds real diversification.
BIB holds far more positions (267 vs 129), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings FBTAX and BIB have in common
| Holding | % of FBTAX | % of BIB | Overlap |
|---|---|---|---|
| Gilead Sciences Inc | 5.70% | 4.66% | 4.66% |
| Alnylam Pharmaceuticals Inc | 3.62% | 2.01% | 2.01% |
| Insmed Inc | 3.05% | 1.16% | 1.16% |
| Revolution Medicines Inc | 3.00% | 1.57% | 1.57% |
| Argenx Se | 3.00% | 1.19% | 1.19% |
| Biogen Inc | 2.71% | 1.44% | 1.44% |
| Amgen Inc | 2.37% | 4.48% | 2.37% |
| Moderna Inc | 1.60% | 0.94% | 0.94% |
| Vertex Pharmaceuticals Inc | 1.39% | 4.65% | 1.39% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in FBTAX
- Abbvie Inc — 14.71%
- Spyre Therapeutics Inc — 3.83%
- Dianthus Therapeutics Inc — 3.55%
- Cogent Biosciences Inc — 3.25%
- Oruka Therapeutics Inc — 3.24%
- Ascendis Pharma A/s — 2.99%
- Mbx Biosciences Inc — 2.45%
- Amylyx Pharmaceuticals Inc — 2.25%
- Vaxcyte Inc — 1.97%
- Fidelity Revere Street Trust — 1.96%
- Relay Therapeutics Inc — 1.58%
- Viridian Therapeutics Inc — 1.53%
- Natera Inc — 1.43%
- Kiniksa Pharmaceuticals International Plc — 1.41%
- Enliven Therapeutics Inc — 1.25%
Only in BIB
- N/a — 7.35%
- ProShares GENIUS Money Market ETF — 6.80%
- N/a — 3.94%
- N/a — 3.26%
- Regeneron Pharmaceuticals, Inc. — 3.21%
- N/a — 2.62%
- Repurchase Agreement — 1.28%
- Illumina, Inc. — 1.25%
- United Therapeutics Corp. — 1.22%
- Royalty Pharma plc — 1.20%
- N/a — 1.18%
- Roivant Sciences Ltd. — 1.08%
- Incyte Corp. — 0.97%
- Viatris, Inc. — 0.94%
- Guardant Health, Inc. — 0.85%
Asset mix
| Asset type | FBTAX | BIB |
|---|---|---|
| Stocks | 98.2% | 63.0% |
| Equity derivatives | — | 16.0% |
| Other | — | 6.8% |
| Repurchase agreements | — | 3.1% |
| Cash & short-term funds | 2.4% | 0.8% |
| Preferred stock | 1.5% | — |
| Bonds | 0.1% | — |
Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)
Country mix
| Country | FBTAX | BIB |
|---|---|---|
| US | 87.8% | 79.8% |
| NL | 4.3% | 1.6% |
| DK | 3.0% | 0.8% |
| KY | 1.8% | 0.4% |
| GB | 1.8% | 1.7% |
| CA | 1.4% | 0.6% |
| BM | 1.2% | 1.1% |
| IE | — | 1.2% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)
Check another pair
FAQ
How much do FBTAX and BIB overlap?
What stocks do FBTAX and BIB have in common?
Should I own both FBTAX and BIB?
Which holds more stocks, FBTAX or BIB?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.